companydata.dkcompanydata.dk

XELLIA PHARMACEUTICALS ApS: Financial statements 2021

CVR: 61094628

Source: annual report 2021, Danish Business Authority

01/01/2021 – 31/12/2021

XELLIA PHARMACEUTICALS ApS (CVR 61094628) has filed annual accounts for 2021. In 2021, the company reported revenue of DKK 1,792,626,000 and a net result of DKK -503,090,000 compared with DKK -115,666,000 the year before. That is a decrease of 12.2% compared with the year before. The profit margin was -28.1%. Equity in the 2021 report amounted to DKK 2,082,735,000. The solvency ratio was 55.8%. The company had 640 employees in the financial year.

Revenue
DKK 1,792,626,000
Gross Profit
DKK -46,989,000
Profit/Loss
DKK -503,090,000
Equity
DKK 2,082,735,000
Total Assets
DKK 3,733,699,000
Employees
640

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
20211.8B-47M-503.1M2.1B640
20202B361.3M-115.7M2.6B624
20192.3B873.5M390.7M1.4B623
20181.9B576.7M-74.9M1B580
20171.9B528.3M91M850.8M493

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like XELLIA PHARMACEUTICALS ApS

Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.

Try the lead list generator

Events in 2021

Søren Hostrup joins the board of XELLIA PHARMACEUTICALS ApSSep 13, 2021

As of September 13, 2021, Søren Hostrup has joined the board of directors of XELLIA PHARMACEUTICALS ApS.

Mikkel Lyager Olsen leaves the board of XELLIA PHARMACEUTICALS ApSSep 13, 2021

As of September 13, 2021, Mikkel Lyager Olsen has left the board of directors of XELLIA PHARMACEUTICALS ApS.

XELLIA PHARMACEUTICALS ApS: The 2020 annual report is outMay 4, 2021

XELLIA PHARMACEUTICALS ApS has published its annual report for 2020. Revenue came to DKK 2,042,515,000, and the net result was DKK -115,666,000.

Lone Thiis joins the board of XELLIA PHARMACEUTICALS ApSApr 30, 2021

As of April 30, 2021, Lone Thiis has joined the board of directors of XELLIA PHARMACEUTICALS ApS.

Jakob Christian Andersen leaves the board of XELLIA PHARMACEUTICALS ApSApr 30, 2021

As of April 30, 2021, Jakob Christian Andersen has left the board of directors of XELLIA PHARMACEUTICALS ApS.

Lone Thiis leaves the board of XELLIA PHARMACEUTICALS ApSApr 29, 2021

As of April 29, 2021, Lone Thiis has left the board of directors of XELLIA PHARMACEUTICALS ApS.

About XELLIA PHARMACEUTICALS ApS

XELLIA PHARMACEUTICALS ApS is a Danish company of the type Anpartsselskab based in København S, founded in 1959. The company is registered under the industry Fremstilling af farmaceutiske råvarer. The company was previously named AXELLIA PHARMACEUTICALS ApS and ALPHARMA ApS. The management consists of Michael Kocher. The board consists of Søren Hostrup (chair), Alexander Sebastian Benjamin Sproedt, Hugo Mendes Marques Crespo Dos Reis and Lars Beck Madsen. The company is owned by XELLIA GROUP ApS. The company has 461 employees (2026). In 2025, the company reported revenue of DKK 1,461,516,000 and a net result of DKK 213,738,000 compared with DKK 828,966,000 the year before. Equity in the 2025 report amounted to DKK 404,569,000.

Source: annual report 2025, Danish Business Authority